✦ LIBER ✦

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases: Figg WD, Liu Y, Arlen P, Gulley J, Steinberg SM, Liewehr DJ, Cox MC, Zhai S, Cremers S, Parr A, Yang X, Chen CC, Jones E, Dahut WL, Center for Cancer Research, National Cancer Institute, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD

✍ Scribed by Donald L. Trump

Book ID: 116955811
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 37 KB
Volume: 23
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2005.06.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A RANDOMIZED, PHASE II TRIAL OF KETOCONA

A RANDOMIZED, PHASE II TRIAL OF KETOCONAZOLE PLUS ALENDRONATE VERSUS KETOCONAZOLE ALONE IN PATIENTS WITH ANDROGEN INDEPENDENT PROSTATE CANCER AND BONE METASTASES

✍ FIGG, W; LIU, Y; ARLEN, P; GULLEY, J; STEINBERG, S; LIEWEHR, D; COX, M; ZHAI, S; 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 474 KB

Randomized phase II trial of docetaxel p

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer: Dahut WL, Gulley JL, Arlen PM, Liu Y, Fedenko KM, Steinberg SM, Wright JJ, Parnes H, Chen CC, Jones E, Parker CE, Linehan WM, Figg WD, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. J Clin Oncol 2004;22:2532–9

✍ Gurkamal Chatta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB